Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
05/01/1993 | CA2099247A1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses |
04/29/1993 | WO1993008302A1 Monoclonal antibodies directed against the microtubule-associated protein tau |
04/29/1993 | WO1993008269A1 A method for enriching fetal progenitor cells from maternal blood |
04/29/1993 | WO1993008268A1 Methods for selectively expanding stem cells |
04/29/1993 | WO1993008267A1 Cell cycle controlling compositions and methods of using same |
04/29/1993 | WO1993008266A1 Preparation of pure cultures of post-mitotic human neurons |
04/29/1993 | WO1993008265A2 Production of bone and nacre from bone-forming cells in the presence of nacre |
04/29/1993 | WO1993008264A1 Colostrum fraction, preparation and use thereof as cell culture media supplement |
04/29/1993 | WO1993008216A1 Human monoclonal antibodies to the cd4-binding domain of hiv, uses thereof and synergistic neutralization of hiv |
04/29/1993 | WO1993008207A1 Novel cytokine |
04/29/1993 | WO1993007913A1 Neomorphogenesis of urological structures in vivo from cell culture |
04/29/1993 | WO1993007889A1 Synthesis of human procollagens and collagens in recombinant dna systems |
04/29/1993 | WO1993007745A1 Method for freezing engrafting cells |
04/29/1993 | CA2122140A1 Method for freezing engrafting cells |
04/29/1993 | CA2122138A1 A method for enriching fetal progenitor cells from maternal blood |
04/29/1993 | CA2121582A1 An improved drugscreening method |
04/29/1993 | CA2120730A1 Preparation of pure cultures of post-mitotic human neurons |
04/28/1993 | EP0538951A2 A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test |
04/28/1993 | EP0538496A1 Recombinant fowlpox virus with intact FPV-tk-gene |
04/28/1993 | EP0538412A1 A cDNA ENCODING THE RAT D 1? DOPAMINE RECEPTOR LINKED TO ADENYLYL CYCLASE ACTIVATION AND EXPRESSION PRODUCT |
04/28/1993 | EP0538404A1 Fibroblast growth factor receptors |
04/28/1993 | EP0538401A1 Novel receptor-type phosphotyrosine phosphatase |
04/28/1993 | EP0538330A1 Beta-alethine use in cell culture and therapy. |
04/28/1993 | EP0538273A1 Alveolar surfactant proteins |
04/28/1993 | EP0538267A1 MONOCLONAL ANTI-IgM ANTIBODIES, THEIR PRODUCTION AND USE, AND HYBRIDOMAS FOR PRODUCING THE SAME |
04/28/1993 | EP0524254A4 A binary genetic system to control expression of a transgene in a transgenic animal |
04/28/1993 | EP0512066A4 Co-independent growth medium for maintenance and propagation of cells |
04/28/1993 | EP0499625A4 Conglutinin fragments, their production and use |
04/28/1993 | EP0338003B1 Monoclonal antibody specific to neutrophils |
04/28/1993 | CN1071456A Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
04/28/1993 | CN1071333A Calcium receptor active molecules |
04/27/1993 | US5206318 Styrene derivatives having N-acetylchito-oligosaccharide chains and method for the same |
04/27/1993 | US5206165 Immortal human mammary epithelial cell sublines |
04/27/1993 | US5206160 Composition containing buf-3 and superoxide dismutase as a cell cleavage promoting agent |
04/27/1993 | US5206015 Introduction of bacteria in ovo |
04/27/1993 | US5206007 Useful in image diagnosis of heart diseases |
04/27/1993 | CA1316853C Growth of cells in a magnetically stabilized fluidized bed |
04/27/1993 | CA1316848C Monoclonal antibody recognizing un-natural ganglioside gd |
04/22/1993 | DE4134297A1 Monoclonal antibody specific for Mycoplasma pneumoniae |
04/21/1993 | EP0537856A1 Monoclonal antibodies to hepatitis C virus |
04/21/1993 | EP0537654A2 Anti-alpha6-integrin-antibodies |
04/21/1993 | EP0537497A2 Monoclonal antibodies against mycoplasma pneumoniae, hybridomas producing it, process for preparing them and their application |
04/21/1993 | EP0537489A1 Monoclonal antibodies against tumor-associated antigens, method for their preparation and their use |
04/21/1993 | EP0537293A1 Ligand for cd28 receptor on b cells and methods |
04/21/1993 | EP0537232A1 Recombinant pigeon pox virus vaccine |
04/21/1993 | EP0537163A1 Transformation of plants with non-structural plant virus gene sequences |
04/21/1993 | EP0537160A1 Expression of recombinant hemoglobin in yeast |
04/21/1993 | EP0323997B1 Recombinant dna expression vectors |
04/20/1993 | US5204258 DNA segment not expressing functional tat protein having ability to trans-activate; not containing entire HIV genome; for developing vaccines, detecting HTLV |
04/20/1993 | US5204244 Production of chimeric antibodies by homologous recombination |
04/20/1993 | US5204243 And vaccine for inducing immunological response in host |
04/20/1993 | CA1316474C Immunogenic conjugates of e. coli lt-b enterotoxin subunit and capsular polymers |
04/19/1993 | CA2078817A1 Anti-.alpha.6-integrin-antibodies |
04/18/1993 | CA2080713A1 Monoclonal antibodies against mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof |
04/17/1993 | WO1993008292A1 Particle-mediated transformation of animal somatic cells |
04/17/1993 | WO1993008213A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine |
04/17/1993 | CA2098599A1 Particle-mediated transformation of animal somatic cells |
04/16/1993 | WO1993008270A1 Particle-mediated transformation of mammalian unattached cells |
04/16/1993 | CA2098498A1 Particle-mediated transformation of mammalian unattached cells |
04/15/1993 | WO1993007294A1 A method of identifying ligands and antagonists of ligands |
04/15/1993 | WO1993007283A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
04/15/1993 | WO1993007281A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
04/15/1993 | WO1993007278A1 Synthetic dna sequence having enhanced insecticidal activity in maize |
04/15/1993 | WO1993007270A1 Production of gpa neurotrophic factor |
04/15/1993 | WO1993007258A1 Cell culture substrate |
04/15/1993 | WO1993006867A1 The regulation of systemic immune responses utilizing cytokines and antigens |
04/15/1993 | WO1993006866A2 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
04/15/1993 | WO1993006844A1 Hormone analogs with multiple ctp extensions |
04/15/1993 | WO1993006714A1 A canola variety producing a seed with reduced glucosinolates and linolenic acid yielding an oil with low sulfur, improved sensory characteristics and increased oxidative stability |
04/15/1993 | WO1993006710A1 Pathogen-resistant transgenic plants |
04/15/1993 | CA2120370A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
04/15/1993 | CA2119580A1 Production of gpa neurotrophic factor |
04/14/1993 | EP0536646A2 Recombinant viruses, their application and production |
04/14/1993 | EP0536364A1 Recombinant dna coding for a novel protein having beta-1,3-glucanase activity of soya |
04/14/1993 | EP0536335A1 Compositions and methods for the prevention and diagnosis of lyme disease |
04/14/1993 | EP0536330A1 Glyphosate tolerant plants |
04/14/1993 | EP0536327A1 Rose plants and methods for their production and genetic transformation |
04/14/1993 | EP0536322A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
04/14/1993 | EP0536299A1 Surface complexed lymphotoxin |
04/14/1993 | EP0536293A1 Increased starch content in plants |
04/14/1993 | EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
04/14/1993 | EP0536234A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof |
04/14/1993 | EP0536213A1 Sexe determining gene |
04/14/1993 | EP0536186A1 Bone and cartilage inductive proteins |
04/14/1993 | EP0380546B1 Polypeptides with type iv collagen activity |
04/14/1993 | CN1070946A Composition for introducing nucleic acid complexes into higher eucaryotic cells |
04/13/1993 | US5202422 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
04/13/1993 | US5202311 Fibroblast growth factor stabilized with salt of sucrose octasulfate |
04/13/1993 | US5202257 Pure DNA which is capable of hybridizing with receptor polynucleotides under mild conditions |
04/13/1993 | US5202253 Activation by calcium compounds |
04/13/1993 | US5202252 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
04/13/1993 | US5202251 Produced by immunization with specific peptide; used to isolate and purify enzyme |
04/13/1993 | US5202227 Control of cell arrangement |
04/13/1993 | US5202120 Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
04/13/1993 | CA1316132C Cdna and gene for human angiogenin (angiogenesis factor) and method of expression |
04/08/1993 | DE4132379A1 Substrat fuer zellkulturen und kultur von zellen oder zellaggregaten Cell cultures and culture substrate for cell aggregates of cells or |
04/08/1993 | CA2079992A1 Mutant human prourokinase |
04/07/1993 | EP0535621A1 Process for the stabilisation of biologically active material |
04/07/1993 | EP0535347A2 Monoclonal antibodies to sulfonated polymers |
04/07/1993 | EP0535161A1 Expression vectors containing the hiv nef gene to enhance replication efficiency |